Dietary Omega-3 Fatty Acids Increase Survival and Decrease Bacterial Load in Mice Subjected to Staphylococcus

Sara L Svahn1, Marcus A Ulleryd1, Louise Grahnemo1,2

  • 1Department of Physiology, Institute of Neuroscience and Physiology, University of Gothenburgy, Gothenburg, Sweden.

Infection and Immunity
|February 10, 2016
PubMed

Insights

Dietary omega-3 fatty acids improve survival in Staphylococcus aureus sepsis. Supplementing with omega-3 fatty acid metabolites also reduced bacterial load, offering a potential therapeutic strategy.

Area of Science:

  • Microbiology
  • Immunology
  • Nutrition Science

Background:

  • Sepsis caused by Staphylococcus aureus is a growing concern, exacerbated by increasing antibiotic resistance.
  • Current pharmacological treatments for sepsis are limited, highlighting the need for alternative therapeutic strategies.
  • Dietary interventions, particularly high-fat diets (HFD), influence sepsis outcomes, with polyunsaturated fatty acids showing promise.

Purpose of the Study:

  • To determine whether omega-3 or omega-6 fatty acids in a high-fat diet (HFD) improve survival in Staphylococcus aureus-induced sepsis.
  • To investigate the therapeutic potential of omega-3 fatty acid metabolites (resolvins) in sepsis.

Main Methods:

  • Mice were fed HFD rich in omega-3 or omega-6 fatty acids for 8 weeks before Staphylococcus aureus inoculation.
  • Mice fed a saturated fatty acid-rich HFD (HFD-S) were treated with resolvins or vehicle control.
  • Survival rates and bacterial loads were assessed post-infection.

Main Results:

  • Mice fed an omega-3 rich HFD exhibited significantly increased survival and reduced bacterial loads compared to those on HFD-S.
  • Treatment with resolvins in HFD-S fed mice led to a decrease in bacterial load compared to vehicle-treated controls.
  • Dietary omega-3 fatty acids appear to counteract the negative effects of HFD-S on sepsis survival.

Conclusions:

  • Dietary omega-3 fatty acids enhance survival and reduce bacterial burden in Staphylococcus aureus sepsis.
  • Resolvins, metabolites of omega-3 fatty acids, demonstrate therapeutic potential in sepsis treatment.
  • Modulating dietary fatty acid intake represents a promising avenue for managing sepsis outcomes.